rs3796123
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_212482.4(FN1):c.1819+7A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.264 in 1,612,308 control chromosomes in the GnomAD database, including 70,263 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_212482.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FN1 | NM_212482.4 | c.1819+7A>T | splice_region_variant, intron_variant | ENST00000354785.11 | NP_997647.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FN1 | ENST00000354785.11 | c.1819+7A>T | splice_region_variant, intron_variant | 1 | NM_212482.4 | ENSP00000346839.4 |
Frequencies
GnomAD3 genomes AF: 0.281 AC: 42694AN: 151986Hom.: 7476 Cov.: 32
GnomAD3 exomes AF: 0.336 AC: 84332AN: 251100Hom.: 19051 AF XY: 0.323 AC XY: 43774AN XY: 135710
GnomAD4 exome AF: 0.263 AC: 383513AN: 1460204Hom.: 62790 Cov.: 32 AF XY: 0.262 AC XY: 190272AN XY: 726526
GnomAD4 genome AF: 0.281 AC: 42709AN: 152104Hom.: 7473 Cov.: 32 AF XY: 0.290 AC XY: 21587AN XY: 74366
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Glomerulopathy with fibronectin deposits 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Spondylometaphyseal dysplasia - Sutcliffe type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at